Less severe hypoglycaemia, better metabolic control and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years

Diabetic Medicine

Volumn 19, Issue 9, 2002, Pages 746-751

  Linkeschova, R ^a   Raoul, M ^a   Bott, U ^a   Berger, M ^a   Spraul, M ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

CSII; Hypoglycaemia; Insulin pump therapy; Quality of life

Indexed keywords

GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN LISPRO;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES CONTROL; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; KETOACIDOSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MORBIDITY; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; SKIN ABSCESS; TREATMENT INDICATION; VALIDATION PROCESS;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE; RETROSPECTIVE STUDIES;

EID: 0036042661     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2002.00713.x     Document Type: Article

References (26)

1. Continuous subcutaneous insulin infusion: An approach to achieving normoglycaemia
2. Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for Type 1 (insulin-dependent) diabetes mellitus: A one centre experience
3. Diet liberalisation and metabolic control in type I diabetic outpatients treated by continuous subcutaneous insulin infusion
4. Effect of patient-selected intensive insulin therapy on quality of life
5. Insulin pump treatment for diabetes: Some questions can be answered already
6. Continuous subcutaneous insulin infusion
7. Continuous subcutaneous insulin infusion (CSII), multiple injections (MI) and conventional insulin therapy (CT) in self-selecting insulin-dependent diabetic patients. A comparison of metabolic control, acute complications and patient preferences
8. Clinical use of the insulin infusion pump in 100 patients with type I diabetes
9. Reduction in severe hypoglycaemia with long-term continuous subcutaneous insulin infusion in type I diabetes
10. Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetes
11. Quality of life activities associated with adherence to insulin infusion pump therapy in the treatment of insulin dependent diabetes mellitus
12. Diabetic ketoacidosis during long-term treatment with continuous subcutaneous insulin infusion
13. Evaluation of insulin pump treatment under routine conditions
14. Mortality among diabetic patients using continuous subcutaneous insulin infusion pumps
15. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy and neuropathy: The Oslo Study
16. Glycemic control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion
17. Continuous subcutaneous insulin infusion versus injection therapy: A randomised crossover trial under usual diabetic clinic conditions
18. Comparison of continuous subcutaneous insulin infusion with multiple insulin injections using the NovoPen
19. A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: Improved control with control with CSII
20. Comparison between continuous subcutaneous insulin infusion and multiple injections of insulin. A one-year prospective study
21. Comparison of continuous subcutaneous insulin infusion and intensified conventional therapy in the treatment of Type I diabetes: A two-year randomised study
22. Continuous subcutaneous insulin infusion (CSII) versus conventional injection therapy in newly diagnosed diabetic children: Two-year follow-up of a randomised, prospective trial
23. Complications and fetal outcome in diabetic pregnancy
24. Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in Type 1 (insulin dependent) diabetes
25. Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes
26. Further development of a quality-of-life measure for IDDM patients